Infants & Toddlers (age in months)

Birth 1 2 4 6 9

Diphtheria and
tetanus toxoids, dose Recommended agepoliovirus:
for catch-up
1st dose; minimum age
2nd6dose
weeks,3rdexception: DTaP-inactivated 4 years
acellular pertussis immunization
(DTaP)

1st dose orally,

Rotavirus (RV) minimum age 6 2nd dose 3rd dose
weeks
 Recomme
nded age
for catch- rd
Hepatitis B (HepB) 1st dose (if2infant
nd
dose> 2 kg) 3 dose
up
immuniza
tion
 Recomme
nded age
for catch- 3rd dose
Hepatitis B (HepB) 1st dose (if2infant
nd
dose> 2 kg) up
immuniza
tion

Hemophilus 1st dose, minimum Recommended age for catch-

influenza type b 2nd dose 3rd dose
age 6 weeks up immunization
(Hib)
 Pneumoc
occal 1st dose; minimum Recommended age for catch-
conjugate 2nd dose 3rd dose up immunization
age 6 weeks
(PCV13)

Pneumoc
occal
vaccines
 polysacch
aride
(PPSV23)

1st dose, minimum

Inactivated poliovirus (IPV) 2nd dose 3rd dose
age 6 weeks

Influenza (IIV, LIAV) Annual immunization (only IVV), 1 or 2 doses

Hepatitis A (HepA)

Human
papillomavirus
(HPV)

Meningococcal Recommended for high-risk groups, minimum age 6 weeks for Hib-MenCY, 2 months
conjugate

Meningococcal B

Recommended for high-risk groups

Measles, mumps,
rubella (MMR) (before traveling outside the US, 1st dose 6 to 11
months before departure; reimmunization with 1st
dose at 12 to 15 months and 2nd dose 4 weeks later)
Varicella (VAR)

Last updated: September 20, 2016

 Toddlers Childhood Adolescence

(age in years) (age in years) (age in years)

9 12 15 18 >2 1.5 – < 2–3 4–6 7–10

ended age for catch-up 4th dose Catch-up 5th dose Catch-up
ation
Recommended age for catch-up immunization
 Recommended age for catch-up immunization

3rd and
ended age for catch- Recommended age for catch-up immunization Recommended for high-risk groups
nization

4th dose: booster

dose
4th dose Recommended age for catch-up immunization Recommended for high-risk groups
 Recommended for high-risk groups, minimum age is

Recommended age Recommended age for catch-u

for catch-up 4th dose routinely recommended for pe
immunization above)

Annual immunization (IVV or LAIV); 1 or 2 doses (2–

n (only IVV), 1 or 2 doses years)
 2-dose series at 12–24 months (time between doses: 6–18 Recommended age for which catch-up is encouraged
months) high-risk groups

Recomme
nded for
high-risk

groups,
minimum
age 9
years

weeks for Hib-MenCY, 2 months for MenACWY-CRM and 9 months for MenACWY-D

MenB vaccine series (2 or 3

Recommended for high-risk

oups
1st dose (minimum
age for non-high-
S, 1st dose 6 to 11 Recommended age for catch-up immunization 2nd dose Recommended age for catch-u
risk groups: 12
mmunization with 1 st months)
nd
dose 4 weeks later)
1st dose Recommended age for catch-up immunization 2nd dose Recommended age for catch-u
 Adult
Adolescence recomme
ndations/
protectio
n
(age in years)

11–12 13–15 16–18

Booste
r doses
Single booster dose of Tdap is of Td
recommended every
10
years

In cases of catch-up immunization, the

single booster dose of Tdap during All pregnant women should receive a single dose of Tdap at 27–36 weeks of gesta
adolescence should not be
administered.

Up to 3
years
after
completio
n of
series
 For at
least
20
years

Individuals who do not respond to a primary 3-dose hep B vaccine series (i.e., anti

p immunization
p immunization

Nonresponders: individuals who have an anti-HBs < 10mIU/mL after 6 doses of h

Duration
of
protectio
n
ended for high-risk groups unknown;
requires
further
investigati
on

Not
lifelon
g
 For all
adults
age ≥
65,
PCV13
vaccin
e is
recom
mende
d
follow
ed by
the
PPSV2
3
vaccin
e 12
month
s later.

ended for high-risk groups

For
people
age <
65
with
certain
high-
risk
conditi
ons,
seque
ntial
PCV13
and
PPSV2
3 are
also
recom
mende
d.

Not
lifelon
g
 Recom
mende
d for
all
adults
≥ 65
years
(see
above)

For
people
age <
65
with
certain
high-
risk
conditi
ons,
seque
ntial
PCV13
and
PPSV2
3 are
also
high-risk groups, minimum age is 2 years recom
mende
d.
high-risk groups, minimum age is 2 years

For
adults
age <
65
who
are
curren
t
smoke
rs or
have a
chroni
c
medic
al
conditi
on,
PPSV2
3
vaccin
e
alone
is
recom
mende
d.

Probably
Recommended age for catch-up immunization (not lifelong
after
routinely recommended for persons aged 18 and completio
above) n of
series

For 1
season; a
yearly
vaccine is
recomme
nded for
all
n (IVV or LAIV); 1 or 2 doses (2–9 years), 1 dose (> 9 patients
every flu
season
(Oct–
April in
northern
hemisphe
re; May–
 For at
least 25
years in
for which catch-up is encouraged; recommended for adults
and 14–
20 years
in
children

No
evidence
of
weakene
d
3-dose Recommended age for catch- protectio
series up immunization n over
time after
completio
n of
series

Booster dose at age 16 if

first dose administered
before 16th birthday Repeat
every 5
1st dose Catch-up immunization years in
recommended for persons high-risk
aged 13–18 years groups

Repeat
MenB vaccine series (2 or 3 doses depending on the brand)
every 5 may be administered to adolescents and young adults aged 16–23 years to
years in
high-risk
groups
Recommended for high-risk groups

Probably
Recommended age for catch-up immunization lifelong
 At least
10–20
years
Recommended age for catch-up immunization after
completio
n of
series